The program trains health care providers various youth health specialties to help them treat adolescents holistically and comprehensively. Photo via BCM.edu

A Houston-based training program focused on training leaders in adolescent and young adult health has just received fresh funding to support its cause.

The Baylor College of Medicine-Texas Medical Center Leadership Education in Adolescent Health, or BCM-TMC LEAH, training program has been awarded a five-year grant totaling $2.3 million. The program is one of only seven such training programs funded by the Health Resources and Services Administration and the Maternal and Child Health Bureau.

“Adolescents make up about 20 percent of the U.S. population yet account for disproportionate rates of mortality from accidents, homicides, suicide, and other conditions related to mental illness,” says Dr. Albert C. Hergenroeder, professor and chief of the division of adolescent medicine and sports medicine and project director for BCM-TMC LEAH, in a news release. “The goal is to train and prepare healthcare professionals to assume leadership roles in the development and improvement of the system of care for adolescents and young adults locally, in Texas, in HRSA Region 6 (Oklahoma, New Mexico, Arkansas and Louisiana), and nationally.”

BCM-TMC LEAH provides didactic, experiential, and research-based interdisciplinary education and training, per the news release, across core health disciplines of medicine, nursing, nutrition, psychology, social work, and public health. It's the fourth time since 1997 the program has received funding.

Along with Hergenroeder, Dr. Connie Wiemann, director of research in the division of adolescent medicine and sports medicine, based at Texas Children’s Hospital, is co-director of the program. The two medical professionals also collaborate with:

  • Dr. Diane Santa-Maria, dean and associate professor in the Department of Research at the University of Texas Health Science Center at Houston Cizik School of Nursing
  • Dr. Christine Markham, chair of health promotion and behavioral sciences and deputy director for the Texas Prevention Research Center at University of Texas Health Science Center at Houston School of Public Health
  • Dr. Sarah Norendorf, associate professor and associate dean for research and faculty development
  • Shelley Gonzales, clinical assistant professor and assistant director of field education at the University of Houston Graduate College of Social Work.

“There has been an increased urgency during the last few years of the need to address adolescent health problems, such as suicide, eating disorders and violence in adolescents,” Hergenroeder says. “These problems require solutions for populations as well as individuals.

"For example," Hergenroeder continues, "an individual patient with an eating disorder will require treatment with an interdisciplinary team of physicians, psychologists, nurses, dietitians and social workers yet for a population, the expertise of researchers and public health experts should look at what broader interventions might be used in the prevention of eating disorders. LEAH is designed to give comprehensive training in all aspects of the threats to adolescent and young adult health in the U.S.”

The program trains pre- and postdoctoral students, medicine fellows, and residents by connecting them with faculty across a multitude of related specialized fields. The trainees then go into communities prepared to holistically treat and focus on problems adolescents and young adults are facing, going beyond just physical and mental health.

“The comprehensive training experience also includes a focus on skills to conduct and disseminate research to promote practices and policies that impact adolescents and young adults in a variety of settings,” said Wiemann. "All trainees will learn tools to engage stakeholders and identify opportunities to improve systems of care. In this way, all disciplines play an important role in improving the health and well-being of this population. And healthcare administrative training is incorporated into the LEAH program so that LEAH trainees will be able to successfully execute great research, clinical, teaching and advocacy programs to improve adolescent and young adult health."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Austin company to bring AI-powered school to The Woodlands

AI education

Austin-based Alpha School, which operates AI-powered private schools, is opening its first Houston-area location in The Woodlands.

The 8,000-square-foot school, scheduled to be ready for the 2026-27 academic year, initially will serve students in kindergarten through eighth grade. Alpha says the school will offer “open workshop spaces and innovative classrooms that support personalized instruction, core academics, leadership development, and real-world life skills.”

Alpha sets aside two hours each school day for the AI-driven, self-paced study of core subjects like math, reading and science. The rest of each school day consists of life-skills workshops focusing on topics such as leadership and financial literacy.

Alpha’s school in The Woodlands has begun accepting applications for the 2026-27 school year. Annual tuition costs $40,000.

“The Woodlands is one of the most dynamic, forward-thinking communities in Texas, and Alpha is proud to bring

an innovative educational model that complements its strong academic foundation,” says Rachel Goodlad, head

of expansion for Alpha.

Founded in 2014, Alpha School combines adaptive technology-driven instruction with immersive life-skills workshops. Its model emphasizes mastery-based learning in core subjects alongside development of communication, critical thinking, financial literacy and leadership skills. It operates more than 15 schools across the country.

Elsewhere in Texas, Alpha operates schools in Austin, Brownsville, Fort Worth and Plano. Alpha also operates 12 Texas Sports Academy campuses in Texas, including locations in Houston, Pearland and Richmond, along with a NextGen Academy esports school in Austin, a school for gifted students in Georgetown, and lower-cost Nova Academy campuses in Austin and Bastrop.

Alpha has fans and critics. While supporters tout students’ high achievement rates, detractors complain about the high tuition and the AI-influenced depersonalization of education.

“Students and our country need to be in relationship with other human beings,” Randi Weingarten, president of the American Federation of Teachers, a teachers union, tells The New York Times. “When you have a school that is strictly AI, it is violating that core precept of the human endeavor and of education.”

Alpha co-founder MacKenzie Price, a podcaster and social media influencer, doesn’t share Weingarten’s views.

“Parents and teachers: We need to embrace this change,” Price wrote after President Trump signed an executive order promoting AI in schools.

The Times notes that Alpha doesn’t employ AI as a tutor or a supplement. Rather, the newspaper says, AI is “the school’s primary educational driver to move students through academic content.”

Houston researcher secures $1.7M to develop drug for aggressive form of breast cancer

cancer research

A University of Houston researcher has joined a $3.2 million effort to develop a new drug designed to attack a cancer-driving protein commonly found in triple-negative breast cancer.

Triple-negative breast cancer (TNBC) is one of the most difficult-to-treat forms of cancer and accounts for 10 percent to 15 percent of all breast cancer cases. The disease gets its name because tumors associated with it test negative for estrogen receptors, progesterone receptors and excess HER2 protein, making it difficult to target. Due to this, TNBC is often treated with general chemotherapy, which can come with negative side effects and drug resistance, according to UH.

UH College of Pharmacy research associate professor Wei Wang is developing a drug that can target the disease more specifically. The drug will target MDM2, a protein often overproduced in TNBC that also contributes to faster tumor growth.

Wang is working on a team led by Wei Li, director of the University of Tennessee Health Science Center College of Pharmacy’s Drug Discovery Center. She has received $1.7 million to support the research.

Wang and UH professor of pharmacology and toxicology Ruiwen Zhang have discovered a compound that can break down MDM2. In early laboratory models, the compound has shown the ability to shrink tumors.

Wang and Zhang will focus on understanding how the treatment works and monitoring its effectiveness in models that closely mirror human disease.

“We will study how the drug targets MDM2 and evaluate the most promising drug candidates to determine effective dosing, understand how the drug behaves in the body, compare it with existing treatments and assess early safety,” Wang said in a news release.

Li’s team at the University of Tennessee will be working on the chemistry and drug design end of the project.

“This work could lead to an entirely new class of therapies for triple-negative breast cancer,” Li added in the release. “We’re hopeful that by directly removing the MDM2 protein from cancer cells, we can help more patients respond to treatment regardless of their tumor type.”